Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Cerezyme (imiglucerase for injection)1件: Imiglucerase (Imiglucerase)2件: Alglucerase ,
Imiglucerase (Imiglucerase) 💬
1件: GBA1 💬 4件: Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
2Cerezyme 400 Units Powder for concentrate for solution for infusionPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: ImigluceraseCAS Number: 154248-97-2Concentration unit: U unit(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use----1件: 19 💬
3Cerezyme® / Imiglucerase1件: Imiglucerase (Imiglucerase)2件: Alglucerase ,
Imiglucerase (Imiglucerase) 💬
1件: GBA1 💬 4件: Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
4IMIGLUCERASE1件: Imiglucerase (Imiglucerase)2件: Alglucerase ,
Imiglucerase (Imiglucerase) 💬
1件: GBA1 💬 4件: Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
5Imiglucerase GZ4378431件: Imiglucerase (Imiglucerase)2件: Alglucerase ,
Imiglucerase (Imiglucerase) 💬
1件: GBA1 💬 4件: Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬